Announcement of the Company holding investor presentation and Significant post press conference

1.Date of occurrence of the event:2016/05/30 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Name of mass media: N/A 6.Content reported: N/A 7.Cause of occurrence: The Company will present the Oral Abstract Sessions at ASCO in afternoon of 4th of […]

This article is password protected.

To view the content, please enter your password in the field below